Khiron Life Sciences Corp.
KHRNF · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $12,795 | $8,017 | $9,582 | $892 |
| % Growth | 59.6% | -16.3% | 974.6% | – |
| Cost of Goods Sold | $6,424 | $1,009 | $7,147 | $594 |
| Gross Profit | $6,371 | $7,008 | $2,436 | $297 |
| % Margin | 49.8% | 87.4% | 25.4% | 33.3% |
| R&D Expenses | $1,216 | $1,526 | $3,733 | $0 |
| G&A Expenses | $21,347 | $25,915 | $31,126 | $18,489 |
| SG&A Expenses | $23,989 | $28,410 | $35,913 | $20,194 |
| Sales & Mktg Exp. | $2,642 | $2,494 | $4,787 | $1,705 |
| Other Operating Expenses | $953 | $678 | $370 | $168 |
| Operating Expenses | $26,158 | $30,613 | $40,016 | $20,194 |
| Operating Income | -$19,787 | -$23,605 | -$37,430 | -$19,896 |
| % Margin | -154.6% | -294.4% | -390.6% | -2,231.3% |
| Other Income/Exp. Net | -$13,807 | -$345 | $1,075 | -$1,103 |
| Pre-Tax Income | -$33,594 | -$23,950 | -$36,355 | -$19,728 |
| Tax Expense | -$465 | $89 | $23 | $79 |
| Net Income | -$33,129 | -$24,039 | -$36,378 | -$19,807 |
| % Margin | -258.9% | -299.8% | -379.6% | -2,221.3% |
| EPS | -0.2 | -0.2 | -0.36 | -0.41 |
| % Growth | 0% | 44.4% | 12.2% | – |
| EPS Diluted | -0.2 | -0.2 | -0.36 | -0.41 |
| Weighted Avg Shares Out | 164,517 | 120,294 | 101,966 | 48,308 |
| Weighted Avg Shares Out Dil | 164,517 | 120,294 | 101,966 | 48,519 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $445 | $468 | $0 | $0 |
| Depreciation & Amortization | $1,115 | $623 | $939 | $338 |
| EBITDA | -$32,034 | -$22,859 | -$36,492 | -$18,287 |
| % Margin | -250.4% | -285.1% | -380.8% | -2,050.9% |